Stryker Neurovascular47900 Bayside Parkwayfremont Ca 94538 Pma Numberp180031 Supplement Numbers005 Date Received09 20 2022 Decision Date11 15 2022 Product Code Qca Advisory Committee Neurology Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Stryker Neurovascular47900 Bayside Parkwayfremont Ca 94538 Pma Numberp180031 Supplement Numbers005 Date Received09 20 2022 Decision Date11 15 2022 Product Code Qca Advisory Committee Neurology Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
Stryker Neurovascular47900 Bayside Parkwayfremont, CA 94538 PMA NumberP180031 Supplement NumberS005 Date Received09/20/2022 Decision Date11/15/2022 Product Code QCA  Advisory Committee Neurology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Neuroform Atlas® Stent System2022-11-15

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.